Parabilis Medicines, Inc. Payments for Commissions
Parabilis Medicines, Inc. (PBLS) reported Payments for Commissions of $57.60 million for the 1-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForCommissions · last filed 2026-08-13
- 2026-06-30: Payments for Commissions 1 month $57.60M.
| Period end | Payments for Commissions 1 month |
|---|---|
| 2026-06-30 | $57.60M 10-Q · filed 2026-08-13 |